T1	Participants 42 71	obsessive-compulsive disorder
T2	Participants 132 161	Obsessive-compulsive disorder
T3	Participants 342 532	patients cannot tolerate the side effects of these medications, the patients do not respond properly to the treatment, or the medications lose their effectiveness after a period of treatment
T4	Participants 870 881	Both groups
T5	Participants 1158 1207	adjuvant agent for obsessive-compulsive disorder,
